Category: Disease States

Disease States

Improved Lyme Disease Tests Could Reduce US Healthcare Costs by 41%

New analysis suggests that higher-sensitivity testing could lower annual spending by more than $3 billion by reducing misdiagnosis.

Disease States

CareDx Completes Acquisition of Cancer Diagnostic Company

The deal adds a blood-based test for viral-mediated cancers to the company’s portfolio of transplant and cell therapy services.

Disease States

Blood Circular RNAs Outperform pTau217 in Predicting Alzheimer’s Disease Progression

A new NIH-funded study finds that elevated circular RNAs in blood may predict Alzheimer’s symptoms years in advance, outperforming current blood tests in forecasting disease progression.

Cancer

Study Supports Multi-Omic Blood Test Strategy for Ovarian Cancer Detection

Researchers identified coordinated lipid, metabolite, and protein signatures in symptomatic patients, supporting a multi-omic strategy for earlier ovarian cancer detection.

Infectious Diseases

Roche Develops Rapid PCR Test for Rare Ebola Bundibugyo Virus

Roche has developed a rapid PCR assay for the rare Ebola Bundibugyo virus, enabling research-use detection within six days to support outbreak response in Central and East Africa, according to the company.

Womens Health

InterVenn, Aranscia Expand Access to Blood-Based Ovarian Cancer Test

The expanded commercialization agreement aims to increase availability of the GlycoKnow Ovarian laboratory-developed test through Aranscia's clinical workflow and technology platforms.

Allergy & Autoimmune

Bringing Clarity to Autoimmune and Allergy Diagnostics

As autoimmune and allergy test volumes rise, labs are prioritizing workflow standardization and structured testing pathways to ensure reliable results, according to Santhosh Nair, president of immunodiagnostics at Thermo Fisher Scientific.

Cardiovascular, Cerebrovascular

FDA Clears New Heart Disease Risk Test for Clinical Labs

The assay measures lipoprotein(a) levels in molar units to improve cardiovascular risk assessment and standardization across laboratories.

Dementias & Alzheimer’s

Blood Test Brings Alzheimer’s Diagnostic Accuracy in Primary Care to Specialist Levels

A blood-based biomarker test enabled primary care physicians to diagnose Alzheimer’s with up to 93% accuracy, comparable to specialists, according to data from a 1,300-patient study presented at AAIC 2026.

Diabetes & Metabolic Diseases

Labcorp Expands Access to Non-Invasive MASH Blood Test Through Online Platform

The NASHnext assay, powered by GENFIT's NIS4 technology, is designed to identify patients with at-risk MASH through a blood draw ordered via the Labcorp OnDemand platform.

Kidney Disease

New Study Links Biomarker Elevations to Kidney Transplant Failure Risk

Elevated donor-derived cell-free DNA levels are linked to higher kidney transplant failure risk, suggesting earlier detection of allograft injury before loss of kidney function.

Respiratory Disease

Yourgene Health Cystic Fibrosis Assay Receives IVDR Accreditation

The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.

Sepsis

FDA Clears New Automated Blood Culture System for Faster Sepsis Detection

The BD BACTEC FXI Culture System reduces detection time for bloodstream infections by approximately three hours compared to previous models.